Compare IHD & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IHD | OPRX |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.9M | 117.1M |
| IPO Year | N/A | 2008 |
| Metric | IHD | OPRX |
|---|---|---|
| Price | $7.54 | $7.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.67 |
| AVG Volume (30 Days) | 69.7K | ★ 121.0K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 10.32% | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | N/A | $3.88 |
| Revenue Next Year | N/A | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $5.93 | $4.54 |
| 52 Week High | $8.14 | $22.25 |
| Indicator | IHD | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 46.54 |
| Support Level | $7.46 | $6.99 |
| Resistance Level | $7.64 | $7.47 |
| Average True Range (ATR) | 0.10 | 0.36 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 30.97 | 32.22 |
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.